Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Clevenger, US
Charles Clevenger, Elmhurst, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100273188 | Serum Prolactin Binding Protein in Epithelial Carcinoma - The present invention relates to antibodies that have specificity towards prolactin binding protein (PRLBP) that is either bound to a binding partner or unbound to a binding partner, as well as antibodies towards PRLBP regardless of the binding state of PRLBP. The present invention also provides methods of using these PRLBP-specific antibodies, such as method of diagnosing and monitoring the progression of diseases such as epithelial carcinomas, osteoporosis, infertility and cachexia. | 10-28-2010 |
Charles V. Clevenger, Elmhurst, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100152104 | Methods for Inhibiting Growth of Prolactin-Responsive Cancer Cells with Cyclosporine A or Other Cyclophilin Inhibitors - Methods are provided for inhibiting growth of prolactin-responsive cancer cells and treating prolactin-responsive malignancies via administration an agent such as cyclosporine A which directly inhibits an enzymatic activity of a cyclophilin. | 06-17-2010 |
Clifford O. Clevenger, Ranchester, WY US
| Patent application number | Description | Published |
|---|---|---|
| 20110008108 | Structure and method for manhole wall sealing - Structures and methods for repair of leaks in the walls of manhole assemblies are provided through use of at least one repair panel comprising a structural member and a sealing member attached to one another. In some embodiments, a plurality of repair panels as provided are present in an end-to-end configuration to yield a seal the extends coextensively with the inner wall surface of a manhole assembly. In some embodiments, a plurality of repair panels as provided are present in an side-by-side configuration on the inner wall surface of a manhole assembly. | 01-13-2011 |
David Clevenger, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090099933 | Total value bidding - Evaluating values of different terms in online auctions is disclosed. An interest rate and a period from a buyer for a lot are obtained. The lot has a predetermined value. A first bid is received from a first bidder and a second bid is received from a second bidder on the lot. The first and second bids each have a payment time and a rebate. The first bid is transformed into a first value and the second bid is transformed into a second value using the interest rate, period, and predetermined value from the buyer and the payment times and rebates from the first and second bidders. | 04-16-2009 |
James Clevenger, Vandalia, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20100330150 | Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs - The present invention is directed to pharmaceutical compositions comprising a plurality of taste-masked high-dose/low-dose drug-containing microparticles, dosage forms comprising such pharmaceutical compositions (such as an orally disintegrating tablet), and methods of making the pharmaceutical compositions and dosage forms of the present invention. Dosage forms comprising the pharmaceutical compositions of the present invention are improved homogeneous blends of high-dose and low-dose drugs which provide for more convenient and palatable administration of drug combinations, for example for treating pain, hyperglycemia, cardiovascular disease, and allergies. | 12-30-2010 |
| 20110003006 | Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics - The present invention is directed to pharmaceutical compositions comprising a plurality of taste-masked non-opioid analgesic/opioid analgesic drug-containing microparticles, dosage forms comprising such pharmaceutical compositions (such as an orally disintegrating tablet), and methods of making the pharmaceutical compositions and dosage forms of the present invention. Dosage forms comprising the pharmaceutical compositions of the present invention are improved homogeneous blends of non-opioid and opioid analgesics which provide for more convenient and palatable administration of drug combinations, for example for treating pain. | 01-06-2011 |
James M. Clevenger, Vandalia, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20090017126 | Modified Release Dosage Forms of Skeletal Muscle Relaxants - A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration—time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period. | 01-15-2009 |
| 20090017127 | Modified Release Dosage Forms of Skeletal Muscle Relaxants - A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration - time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period. | 01-15-2009 |
| 20090148532 | Preparation of controlled release skeletal muscle relaxant dosage forms - The present invention is directed to a method of preparing an extended release pharmaceutical composition comprising cyclobenzaprine, comprising coating inert particles with a cyclobenzaprine-containing the drug layering composition and a seal coating composition to form IR beads, then coating the IR beads with an extended release coating to form ER beads. | 06-11-2009 |
| 20090169620 | ORALLY DISINTEGRATING TABLET COMPOSITIONS OF TEMAZEPAM - The compositions of the present invention are orally disintegrating tablet compositions comprising a therapeutically effective amount of at least one drug such as temazepam, 0.5-3% of an ODT binder polymer, a sugar alcohol and/or saccharide, and a disintegrant. | 07-02-2009 |
| 20100098832 | PREPARATION OF CONTROLLED RELEASE SKELETAL MUSCLE RELAXANT DOSAGE FORMS - The present invention is directed to a method of preparing an extended release pharmaceutical composition comprising cyclobenzaprine, comprising coating inert particles with a cyclobenzaprine-containing a drug layering composition to form IR beads, then coating the IR beads with an extended-release coating to form ER beads. | 04-22-2010 |
| 20110129530 | Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture - There is provided a method for preparing a pharmaceutical composition comprising compressible coated, taste-masked and/or controlled-release coated drug-containing particles, rapidly-dispersing microgranules comprising a disintegrant and a sugar alcohol, a saccharide, or a mixture thereof, and other optional, pharmaceutically acceptable excipients wherein the orally disintegrating tablet (ODT) or rapidly dispersing tablet (RDT) composition having acceptable tableting, organoleptic, and pharmacokinetic properties. | 06-02-2011 |
| 20110217384 | Modified Release Dosage Forms of Skeletal Muscle Relaxants - A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration—time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period. | 09-08-2011 |
Jed Thomas Clevenger, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100161399 | INSTANT PAYOUT INCENTIVE SYSTEM - Methods, apparatus, and systems to process transactions in a networked communication system, including cash back rebate eligible transactions. Some embodiments provide for distributed risk analysis of transactions, such as to provide for a probability analysis of transaction completion at a payment server. The payment server then makes a recommendation for reward timing or payout of a cash back reward. | 06-24-2010 |
John Clevenger, Antioch, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20100006483 | Replaceable filter elements including unique pressure relief and systems including same - According to one embodiment a replaceable filter element includes a substantially annular filter media extending from a first end to a second end and has an exterior, a substantially hollow interior, and a first permeability. A first end plate is coupled to the first end of the substantially annular filter media. The first end plate includes an aperture leading to the substantially hollow interior of the substantially annular filter media. The replaceable filter element includes a filter media piece positioned adjacent the second end of the substantially annular filter media and has a second permeability less than the first permeability. The replaceable filter element includes an outer wrap extending from the second end of the substantially annular filter media along a portion of the exterior of the substantially annular filter media. Further embodiments, forms, objects, features, advantages, aspects, and benefits shall become apparent from the following description and drawings. | 01-14-2010 |
Larry A. Clevenger, Lagrangeville, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080258308 | Method of controlled low-k via etch for Cu interconnections - An interconnect stack and a method of manufacturing the same wherein the interconnect has vertical sidewall vias. The interconnect stack includes a substrate, a metal interconnect formed in the substrate, an etch stop formed on the substrate and the metal interconnect, and an interlayer dielectric (ILD) layer having at least one via formed therein extending through a transition layer formed on the etch stop layer. The via is formed by etching the ILD to a first depth and ashing the interconnect stack to modify a portion of the ILD between the portion of the via formed by etching and the transition layer. Ashing converts this portion of the ILD to an oxide material. The method includes wet etching the interconnect to remove the oxide material and a portion of the transition layer to form a via extending through the ILD to the etch stop layer. | 10-23-2008 |
Lawerence A. Clevenger, Hopewell Junction, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110108989 | PROCESS FOR REVERSING TONE OF PATTERNS ON INTEGERATED CIRCUIT AND STRUCTURAL PROCESS FOR NANOSCALE FABRICATION - A process to produce an airgap on a substrate having a dielectric layer comprises defining lines by lithography where airgaps are required. The lines' dimensions are shrunk by a trimming process (isotropic etching). The tone of the patterns is reversed by applying a planarizing layer which is etched down to the top of the patterns. The photoresist is removed, leading to sub-lithographic trenches which are transferred into a cap layer and eventually into the dielectric between two metal lines. The exposed dielectric is eventually damaged, and is etched out, leading to airgaps between metal lines. The gap is sealed by the pinch-off occurring during the deposition of the subsequent dielectric. | 05-12-2011 |
Lawrence Clevenger, Lagrangeville, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090111235 | Semiconductor Integrated Circuit Devices Having High-Q Wafer Back-Side Capacitors - Methods are provided for fabricating semiconductor IC (integrated circuit) chips having high-Q on-chip capacitors formed on the chip back-side and connected to integrated circuits on the chip front-side using through-wafer interconnects. In one aspect, a semiconductor device includes a semiconductor substrate having a front side, a back side, and a buried insulating layer interposed between the front and back sides of the substrate. An integrated circuit is formed on the front side of the semiconductor substrate, an integrated capacitor is formed on the back side of the semiconductor substrate, and an interconnection structure is formed through the buried insulating layer to connect the integrated capacitor to the integrated circuit. | 04-30-2009 |
| 20090312046 | INTELLIGENT WIRELESS POWER CHARGING SYSTEM - A system and methodology for intelligent power management of wirelessly networked devices. The system provides for reliable wireless communication via a wireless power charging method and, a method to maintain power capacity of batteries in a wireless device. The batteries are charged via an RF harvesting unit embedded inside the wireless device. An intelligent wireless power charging system further comprises at least two batteries and at least two RF adaptor devices coupled to an AC power line. The first adaptor is set for data communication while the second adaptor is used to transmit the power. In addition, when a first battery is in use during active mode, the second battery is subjected to wireless charging. | 12-17-2009 |
Lawrence A. Clevenger, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110100443 | Photovoltaic solar cell device manufacture - A method for manufacturing a photovoltaic solar cell device includes the following. A p-n junction having a first doping density is formed. Formation of the p-n junction is enhanced by introducing a second doping density to form high doped areas for a dual emitter application. The high doped areas are defined by a masking process integrated with the formation of the p-n junction, resulting in a mask pattern of the high doped areas. A metallization of the high doped areas occurs in accordance with the mask pattern of the high doped areas. | 05-05-2011 |
| 20110100453 | Electrically contactable grids manufacture - A method for manufacturing one or more electrically contactable grids on at least one surface of a semiconductor substrate for use in a solar cell product includes the following. A heat-sensitive masking agent layer is deposited on the surface of the substrate of the solar cell product. The masking agent layer is locally heated to form a grid mask. Selected parts of the masking agent layer defined by locally heating are removed to form openings in the grid mask. A contact metallization is applied on the grid mask. | 05-05-2011 |
Lawrence A. Clevenger, Armonk, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110020753 | Method for reversing tone of patterns on integrated circuit and patterning sub-lithography trenches - A method for reversing the tone of a lithographic image on a substrate comprises depositing a modifiable material on a substrate; applying a photolithographic material on the modifiable material: defining a removable patterned area in the photolithopgraphic material by photolithograpic means; removing the patterned area to produce an exposed region in the modifiable material that substantially conforms to the patterned area; producing a reacted modifiable material by increasing the etch resistance of the modifable material substantially throughout the exposed region so that the etch resistance of the exposed region comprises a region that substantially conforms to the exposed region; and removing the photoresist and the modifiable material to leave the reacted modifiable material and substrate. | 01-27-2011 |
Lawrence A. Clevenger, La Grangeville, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080231312 | Structure for modeling stress-induced degradation of conductive interconnects - A structure representative of a conductive interconnect of a microelectronic element is provided, which may include a conductive metallic plate having an upper surface, a lower surface, and a plurality of peripheral edges extending between the upper and lower surfaces, the upper surface defining a horizontally extending plane. The structure may also include a lower via having a top end in conductive communication with the metallic plate and a bottom end vertically displaced from the top end. A lower conductive or semiconductive element can be in contact with the bottom end of the lower via. An upper metallic via can lie in at least substantial vertical alignment with the lower conductive via, the upper metallic via having a bottom end in conductive communication with the metallic plate and a top end vertically displaced from the bottom end. The upper metallic via may have a width at least about ten times than the length of the metallic plate and about ten times smaller than the width of the metallic plate. The structure may further include an upper metallic line element in contact with the top end of the upper metallic via. | 09-25-2008 |
| 20080246151 | INTERCONNECT STRUCTURE AND METHOD OF FABRICATION OF SAME - A damascene wire and method of forming the wire. The method including: forming a mask layer on a top surface of a dielectric layer; forming an opening in the mask layer; forming a trench in the dielectric layer where the dielectric layer is not protected by the mask layer; recessing the sidewalls of the trench under the mask layer; forming a conformal conductive liner on all exposed surface of the trench and the mask layer; filling the trench with a core electrical conductor; removing portions of the conductive liner extending above the top surface of the dielectric layer and removing the mask layer; and forming a conductive cap on a top surface of the core conductor. The structure includes a core conductor clad in a conductive liner and a conductive capping layer in contact with the top surface of the core conductor that is not covered by the conductive liner. | 10-09-2008 |
Lawrence Alfred Clevenger, Lagrangeville, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100001253 | Method for delineation of phase change memory cell via film resistivity modification - A PCM cell structure comprises a first electrode, a phase change element, and a second electrode, wherein the phase change element is inserted in between the first electrode and the second electrode and only the peripheral edge of the first electrode contacts the phase change element thereby reducing the contact area between the phase change element and the first electrode and thereby increasing the current density through the phase change element and effectively inducing the phase change at lower levels of current and reduced programming power. | 01-07-2010 |
Loren Clevenger, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20090240572 | BUSINESS TRANSACTION REPORTING SYSTEM - An embodiment of the present invention provides a business transaction reporting system for use in tracking revenue from entertainment commodities distributed by one or more distribution parties. The distribution of the entertainment commodities is conducted through a plurality of entities that are independent from the distribution parties. In the embodiment, at least two of the entities are independent from one another. The system includes a plurality of point-of-sale (POS) computers operated at a plurality of locations. Each computer is operated by one of the independent entities and each POS computer hosts an application for recording entertainment unit transactions related to the entertainment commodities. The system further includes a central host computer system coupled to the POS computers to receive an accounting of the entertainment unit transactions, and a database configured to store, process, and report on the entertainment unit transactions. | 09-24-2009 |
Marvin Brad Clevenger, Albuquerque, NM US
| Patent application number | Description | Published |
|---|---|---|
| 20100224239 | Multijunction solar cell with a bypass diode - In a preferred embodiment, a layer of TiAu is placed in an etch in a solar cell with a contact at a doped layer of GaAs. Electric current is conducted through a diode and away from the main cell by passing through the contact point at the GaAs and traversing a lateral conduction layer. These means of activating, or “turning on” the diode, and passing the current through the circuit results in greater efficiencies than in prior art devices. The diode is created during the manufacture of the other layers of the cell and does not require additional manufacturing. | 09-09-2010 |
Nathan J. Clevenger, Burnsville, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110258595 | Cross-Platform Application Framework - One set of instructions is generated in part by compiling application-specific source code. When natively executed on a platform provided by a device, the set of instructions provides an application. Another set of instructions is generated in part by compiling the same business logic source code. When natively executed on another platform provided by another device, the other set of instructions provides the same application. The business logic source code is substantially free of code specific to any platform. Moreover, the business logic source code defines substantially all application-specific functionality of the application. | 10-20-2011 |
Randall R. Clevenger, Mount Airy, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20080269718 | Method for pressure mediated selective delivery of therapeutic substances and cannula - Methods and devices are disclosed for selective delivery of therapeutic substances to specific histologic or microanatomic areas of organs. Introduction of the therapeutic substance into a hollow organ space (such as an hepatobiliary duct or the gallbladder lumen) at a controlled pressure, volume or rate allows the substance to reach a predetermined cellular layer (such as the ephithelium or sub-epithelial space). The volume or flow rate of the substance can be controlled so that the intralumenal pressure reaches a predetermined threshold level beyond which subsequent subepithelial delivery of the substance occurs. Alternatively, a lower pressure is selected that does not exceed the threshold level, so that delivery occurs substantially only to the epithelial layer. Such site specific delivery of therapeutic agents permits localized delivery of substances (for example to the interstitial tissue of an organ) in concentrations that may otherwise produce systemic toxicity. Occlusion of venous or lymphatic drainage from the organ can also help prevent systemic administration of therapeutic substances, and increase selective delivery to superficial epithelial cellular layers. Delivery of genetic vectors can also be better targeted to cells where gene expression is desired. The access device comprises a cannula with a wall piercing tracar within the lumen. Two axially spaced inflatable balloons engage the wall securing the cannula and sealing the puncture site. A catheter equipped with an occlusion balloon is guided through the cannula to the location where the therapeutic substance is to be delivered. | 10-30-2008 |
Randell Clevenger, North Plainfield, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100215643 | ANTI-INFECTIVE FUNCTIONALIZED SURFACES AND METHODS OF MAKING SAME - Devices are provided which are functionalized to include surface regions having anti-infective agents. Methods are provided for functionalizing various material surfaces to include active surface regions for binding anti-infective agents. Methods are provided by which anti-infective moieties or agents are bonded to functionalized surfaces. | 08-26-2010 |